Pharmaceutical Executive
January 01, 2008
Washington Report
0
0
Pricing, safety, comparative effectiveness, patents, and biosimilars top 2008's policy agenda
January 01, 2008
Column
0
0
We asked seven industry experts to talk about today's best (and worst) pharma icons
January 01, 2008
Global Report
0
0
Pharma defends itself against claims made in charity's report on drug access for the world's poor
January 01, 2008
Tech
0
0
More control over warehouse data (from drug company to pharmacist) is key to inventory control
January 01, 2008
Features
0
0
Pharm Exec asks experts to predict what 2008 has up its sleeve for the industry--from the top line to the bottom line, from R&D to M&As, from Congress to the courts.
January 01, 2008
From the Editor
0
0
A new report says FDA is desperately behind on science. At last, a critique we can actually do something about. But will we?
January 01, 2008
Leadership
0
0
The departure of Wyeth's legendary CEO prompts a reflection on true leadership-and cooking
January 01, 2008
Features
0
0
Welcome to the new employer's market for reps. The Hay Group's annual survey reports how, as the primary sales force contracts, so too does its pay.
January 01, 2008
Toolkit
0
0
When it comes to clinical teams, the question of whether or not to outsource brings some untraditional answers
January 01, 2008
Column
0
0
Pharma companies would do well to proceed with extreme caution when entering the blogosphere
January 01, 2008
Features
0
0
Novartis' Paul Herrling talks about how Big Pharma can learn from nonprofit R&D and collaborate to get an edge on the drug safety problem.